7/26/2019 12.2.09 Crocker SLE
1/24
Systemic Lupus
Erythematosus
Justin A. CrockerAM Report 12/2/09
7/26/2019 12.2.09 Crocker SLE
2/24
SLE
Autoimmune disease that aects mu!tisystems 1." mi!!ion cases o !upus
#re$a!ence o 1% to &' per 100(000 popu!ation )omen * Men + 9,1 ratio 90- cases are omen Arican Americans * )hites
nset usua!!y eteen aes o 1" and &" years(ut
Can occur in chi!dhood or !ater in !ie
7/26/2019 12.2.09 Crocker SLE
3/24
C!inica! Maniestations
or the purpose o identiyin patients inc!inica! studies( a person has SLE i & or
more o the 11 criteria are present( seria!!yor simu!taneous!y( durin any inter$a! ooser$ation. 3speciicity 9"-( sensiti$ity%"-4
5t is important to rememer that a patientmay ha$e SLE and not ha$e & criteria.
7/26/2019 12.2.09 Crocker SLE
4/24
Criteria
1. 6utter!y rash
2. 7iscoid !upus
8. #hotosensiti$ity
&. ra! u!cers
". Arthritis
. Serositis
%. :euro!oic d/o
'. ;emato!oic d/o
9. Rena! d/o
10.5mmuno!oic, anti+
7:A( anti+Sm( a!se
pos S
7/26/2019 12.2.09 Crocker SLE
5/24
Cutaneous
Most common rash is photosensiti$e( raisederythematous ma!ar rash. ""+'"- de$e!op atsome point in disease
7iscoid Lupus Erythematosus 37LE4, 1"+80-circu!ar( sca!y hyperpimented !esions itherythematous rim( atrophic center=can edisiurin
Mouth/$aina!/nasa! u!cers A!opecia, may e diuse or patchy. ccurs "0-
7/26/2019 12.2.09 Crocker SLE
6/24
Ma!ar Rash
7/26/2019 12.2.09 Crocker SLE
7/24
7iscoid Rash
7/26/2019 12.2.09 Crocker SLE
8/24
ra! >!cers
7/26/2019 12.2.09 Crocker SLE
9/24
MS?
#o!yarthritis( mi!d to disa!in( occurs mostre@uent!y in hands( rists( knees. ccurs 90-
Joint deormities occur in on!y 10- Arthritis o SLE tends to e transitory 5 sin!e oint has persistent pain( consider
osteonecrosis 3pre$a!ence increased in SLE o$erenera! popu!ation( especia!!y i on steroids.4
Myositis ith e!e$ated C? and eakness rare!yoccurs
7/26/2019 12.2.09 Crocker SLE
10/24
Arthritis
7/26/2019 12.2.09 Crocker SLE
11/24
Serositis + #u!monary
#!euritis ith or ithout eusion
+ i case is mi!d( tB, :SA57S
+ i case is se$ere( tB, steroids Lie+threatenin maniestations, interstitia!
in!ammation hich can !ead to irosis and
intra+a!$eo!ar hemorrhae. A!so pneumothoraB and pu!monary ;
7/26/2019 12.2.09 Crocker SLE
12/24
Serositis Cardiac
#ericarditis, most common cardiac maniestation
and usua!!y responds to :SA57s.
Myocarditis 3rare4 and irinous endocarditis3Liman+Sacks4 may occur. Steroids p!us
treatment or C;/arrhythmia or emo!ic e$ents.
M5 due to atherosc!erosis can occur in D8" y/o
7/26/2019 12.2.09 Crocker SLE
13/24
:euro
Crania! or periphera! neuropathy occurs in 10+1"-( it isproa!y secondary to $ascu!itis in sma!! arteriessupp!yin ner$es.
7iuse C:S dysunction, memory and reasonindiicu!ty ;eadache, i eBcruciatin( oten indicate acute !are Seiures o any type #sychosis, must distinuish rom steroid+induced
psychosis 3occurs in 1steeks o tB at doses F&0mprednisone and reso!$es ater se$era! days o reducinor stoppin tB4
7/26/2019 12.2.09 Crocker SLE
14/24
Cont.
7/26/2019 12.2.09 Crocker SLE
15/24
;eme
Anemia, usua!!y :ormochromic(
normocytic
Leukopenia, a!most a!ays consists o!ymphopenia( not ranu!ocytopenia
7/26/2019 12.2.09 Crocker SLE
16/24
Rena!
:ephritis, usua!!y asymptomatic( so
a!ays check >A i patient has knon or
suspected SLE ccurs ear!y in course o disease+i not
present /in 1 yr( proa!y i!! not occur.
;isto!oic c!assiication y rena! iopsy isuseu! to p!an therapy
7/26/2019 12.2.09 Crocker SLE
17/24
;isto!oic C!assiications C!ass 5 is minima! mesania! !omeru!onephritis hich is
histo!oica!!y norma! on !iht microscopy ut ith mesania!deposits on e!ectron microscopy.
C!ass 55 is ased on a indin o mesania! pro!ierati$e !upusnephritis.
7/26/2019 12.2.09 Crocker SLE
18/24
5mmuno!ou!ins
Anti+ds7:A 5H, $ery speciic( may
corre!ate ith disease acti$ity
Anti+Sm, speciic( ut on!y present in 2"-o cases( does not corre!ate ith acti$ity
A#LA, not speciic. >sed to identiy
patients at increased risk or c!ots(thromocytopenia and eta! !oss
7/26/2019 12.2.09 Crocker SLE
19/24
A:A
A:A, positi$e in 9"- o cases. #retest
proai!ity aects interpretation. 5n #C# settin(
2- or SLE. 5n rheum, 80- Lo #ositi$e 31,10 or !oer4, SLE !ike!ihood
D2- 3D2- or rheumato!oists4
;ih #ositi$e 31,820 or hiher4, SLE !ike!ihood,
2+1%- 382+'1- or rheumato!oists4
SLE speciic patterns, Rim and ;omoenous
7/26/2019 12.2.09 Crocker SLE
20/24
Additiona! ork+up
+ Serum cr. and a!umin
+ C6C / di
+ >/A
+ ESR
+
Comp!ement !e$e!s+ Rena! B i arranted
7/26/2019 12.2.09 Crocker SLE
21/24
7/26/2019 12.2.09 Crocker SLE
22/24
Conser$ati$e manaement
or those /out maor oran in$o!$ement. :SA57s, to contro! pain( se!!in( and e$er
Caution / :SA57S thouh. SLE pts are atincreased risk or aseptic meninitis
Antima!aria!s, Henera!!y to treat atiue ointpain( skin rashes( and in!ammation o the !uns
Common!y used, ;ydroBycho!or@uine >sed a!one or in comination ith other drus
7/26/2019 12.2.09 Crocker SLE
23/24
Cont.
Corticosteroids 3Mainstay o SLE treatment4
sua!!y start ith hih+dose 5G pu!se and con$ertto # steroids ith oa! o taperin and
con$ertin to somethin e!se.
Common!y used, prednisone( hydrocortisone(methy!predniso!one( and deBamethasone
7/26/2019 12.2.09 Crocker SLE
24/24
5mmunosuppressi$es
#rimari!y or C:S/rena! in$o!$ement Mycopheno!ate moeti! 3ce!!cept4 Aathioprine 3imuran4, re@uires se$era! months to e
eecti$e( eecti$e in sma!!er percentae o patients M